Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

Clinical trial NCT06263543 · RECRUITING

Trial details

NCT number: NCT06263543
Sponsor: Reshma L. Mahtani, D.O.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Advanced Breast Cancer Hormone-receptor-positive Breast Cancer Human Epidermal Growth Factor 2 Low Breast Cancer

Start date: 2024-06-17
Primary completion: 2028-06-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.